Skip to main content

RETRACTION article

Front. Oncol., 10 June 2021
Sec. Cancer Molecular Targets and Therapeutics
This article is part of the Research Topic Nanomedicine in Cancer Targeting and Therapy View all 13 articles

Retraction: Chitosan-Coated Titanium Dioxide-Embedded Paclitaxel Nanoparticles Enhance Anti-Tumor Efficacy Against Osteosarcoma

Frontiers Editorial Office* Frontiers Editorial Office*
  • Frontiers Media SA, Lausanne, Switzerland

A Retraction of the Original Research Article
Chitosan-Coated Titanium Dioxide-Embedded Paclitaxel Nanoparticles Enhance Anti-Tumor Efficacy Against Osteosarcoma

By Qu Y., Kang M., Cheng X., & Zhao J. (2020). Front. Oncol. 10:577280. doi: 10.3389/fonc.2020.577280

The Journal and Authors retract the 9 September 2020 article cited above for the following reasons provided by the Authors:

Following publication, concerns were raised regarding image manipulation. The authors failed to provide a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers’ policies.

This retraction was approved by the Chief Editors of Frontiers in Oncology and Chief Executive Editor. The authors agree to this retraction.

Citation: Frontiers Editorial Office (2021) Retraction: Chitosan-Coated Titanium Dioxide-Embedded Paclitaxel Nanoparticles Enhance Anti-Tumor Efficacy Against Osteosarcoma. Front. Oncol. 11:712966. doi: 10.3389/fonc.2021.712966

Received: 21 May 2021; Accepted: 21 May 2021;
Published: 10 June 2021.

Approved by:

Giuseppe Giaccone, Cornell University, United States

Copyright © 2021 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Editorial Office, ZWRpdG9yaWFsLm9mZmljZUBmcm9udGllcnNpbi5vcmc=

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.